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The periodic paralyses are a group of autosomal dominant muscle diseases 
sharing the common feature of episodic stiffness and weakness, usually occur- 
ring with muscle cooling (as in the case of paramyotonia congenita, PC pheno- 
type) or changes in extracellular K+ levels resulting from various precipitating 
factors (hyperkalemic periodic paralysis, HYPP and hypokalemic periodic 
paralysis, HypoPP). 
It is now known that HYPP maps to chromosome 17q, and that PC and a form of 
myotonia congenita without periodic paralysis also map to the 17q locus, thus 
indicating that they derive from allelic variants. So far, these disorders have been 
described in various ethnic groups but, to our knowledge, have never been re- 
ported in Italy. 
We describe a mutation in an $4 segment of the adult skeletal muscle sodium 
channel in a clinically-defined Italian family that leads to the paramyotonia con- 
genita (PC) phenotype with dominant autosomal inheritance and temperature- 
related symptoms (regional weakness following cooling and exercise), present 
since childhood in all of the affected family members. 
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Introduction 
The periodic paralyses are a group of autosomat 
dominant muscle diseases in which attacks of 
paralysis and myotonia may occur spontaneously 
or be precipitated by specific factors including 
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exercise, alterations in extracellular potassium 
levels and muscle cooling [22]. 
In hyperkalemic periodic paralysis (HYPP), the 
symptoms and signs are worsened by elevated 
serum potassium levels (thus making it possible 
to distinguish such patients from those with hy- 
pokalemic periodic paralysis, HypoPP) [7]. 
In another form of periodic paralysis, PC, the 
paralysis is temperature-sensitive andusually oc- 
curs with muscle cooling. Cold-induced, pro- 
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longed, localized myotonia nd subsequent tran- 
sient weakness are the hallmarks of PC. Muscle 
activity aggravates PC-associated myotonia (par- 
adoxical myotonia) in contrast o the improve- 
ment with exercise that occurs in patients with 
other myotonic disorders (classic myotonia). Most 
PC patients demonstrate some degree of myoton- 
ic worsening with K + loading. However, in some 
cases the attacks of weakness are associated with 
normo- or hypokalemia [21], even though there 
are patients with the features of both HYPP and 
PC [24, 27]. 
Electrophysiological investigations of HYPP and 
PC muscle in vitro have revealed an alteration in 
muscle membrane sodium conductance [26, 15], 
suggesting that sodium channels are involved in 
the pathogenesis of periodic paralysis [16, 12]. 
This is supported by the genetic linkage of 
SCN4A (the gene encoding the adult isoform of 
the Na channel) to HYPP and PC. The unique 
features of PC suggest hat one or more muta- 
tions in SCN4A, different from those causing 
HYPP, might be responsible for the disorder [7, 
19, 13, 5, 23, 10]. 
In the present series of experiments, ingle strand 
conformation polymorphism analyses were car- 
ried out in an Italian PC family to ascertain 
whether the PC phenotype xpressed according to 
an autosomal dominant pattern of inheritance was 
effectively due to an alteration in the $4 segment 
of the adult skeletal sodium channel, and whether 
this corresponded to one of the known mutations 
so far described [20, 25, 17, 5, 6]. 
Pafien~ 
C~e I 
This patient (V-2) is a 52-year-old woman who 
has experienced cold-induced stiffness since in- 
fancy. On exposure to cold, her hands, feet and 
orbicularis oculi become stiff, cramped and 
slightly weakened for several hours after the stif- 
fening event. There is no correlation with carboh- 
ydrate or liquorice ingestion, fasting or physical 
exercise. The patient has a previous history of 
thyroid involvement (hyperthyroidism, well com- 
pensated by substitution therapy after partial re- 
moval of the gland) and allergy to a number of 
antibiotics and anti-phlogistic drugs. 
The symptoms and signs have never become life- 
threatening, but the complaint is such that the pa- 
tient has to limit all outdoor activities during win- 
ter-time and, in general, avoid any excessive 
cooling of her hands by normally using warm 
water from the tap. The patient came to our ob- 
servation when she was treated with a beta-agon- 
ist and a thiazid diuretic (chlorthalidone) which 
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failed to prevent he attacks. 
Neurological examination showed a general hy- 
pertrophy, which was more evident in the gas- 
trocnemius of both legs. The muscle of the an- 
tero-lateral aspect of the legs was instead moder- 
ately hypotrophic (the tibial crest was evident). 
Mechanical percussion of the right thenar emin- 
ence suggested a slight myotonic phenomenon. 
Case 2 
This patient (IV-5) is a 63-year-old man who first- 
noticed stiffness in his hands at the age of 30, ar- 
ound the time he started working as a butcher. He 
could not enter the cold-chamber because the 
stiffness and cramping of his hands was so marked 
that he was obliged to put down what he was 
holding and rest his hands for a half-hour follow- 
ing the stiffening event. No treatment was ever 
tried. 
Neurological examination was completely nor- 
mal. 
Case 3 
This patient (VI-2) is a 31-year-old woman who 
is completely asymptomatic except for a mild de- 
glee of general weakness during the winter. No 
stiffening event has ever been described. 
Neurological examination revealed a general hy- 
pertrophy that was more evident in the gastroc- 
nemius of both legs, but no other sign of muscle 
involvement was observed. 
Case 4 
This patient (VI-3) is a 21-year-old man who has 
experienced muscle stiffening since childhood. 
The orbicularis oculi are mainly affected, but the 
complaint was disturbing only when he failed to 
protect his face with a scarf during excessively 
low temperatures. No other symptom was des- 
cribed until he reached 17-18 years of age, when 
he started experiencing mild stiffness in his hands. 
These disorders are not associated with any form 
of muscle weakness and he also practices judo. 
Neurological examination revealed general hy- 
pertrophy but no signs of muscle involvement. 
Case 5 
This patient (VI-4) is a 19-year-old man who is 
the most affected member of the family. Since the 
age of 14, he was often obliged to stop driving 
his scooter because of his inability to open his 
hand to disengage the clutch or because he 
couldn't keep his eyes sufficiently open to drive 
properly. Sometimes he is able to ward off the 
event by means of gentle exercise (i.e. opening 
and closing his hands or eyes) and by avoiding 
excessive xposure to cold; at other times, com- 
plete recovery requires several hours and occa- 
sionally a few days, especially because of a wan- 
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sient form of weakness following the event. No 
myalgia, cramps, stiffening or weakness is exper- 
ienced between attacks, and he practises judo at a 
high sporting level. 
Neurological examination showed well-devel- 
oped, almost "sculptured" muscles but no sign of 
muscle involvement. 
Materials and methods 
The family tree indicated in Figure 1 includes 34 
members over VII generations, with 4 provenly 
affected individuals and 12 affected by history. 
Diagnosis was based on the history of the mem- 
bers of the I and III generation, and the history 
and direct evaluation of the members of the IV, 
V and VI generations. No data were available for 
the members of the II generation. 
The patients described above underwent routine 
haematological tests to check for any abnormali- 
ties in electrolytes at rest and after potassium 
loading. This latter test was carried out according 
to Streib et al. [29]: after fasting the patient was 
given 4g of K § to drink in an unsweetened solu- 
tion and isometric muscle exercises were done for 
about 3 minutes after potassium loading. During 
the test, K § levels were examined at baseline 
(control, before K § loading) and every 30 min- 
utes. Blood pressure and ECG recordings were 
also checked for any type of cardiac involvement. 
Electrophysiological recordings (EMG studies) 
were carried out under baseline conditions and 
after exposure to cold in accordance with stan- 
dard protocols [12]. 
Muscle biopsies were performed on the left bi- 
ceps brachii under local anaesthesia with the con- 
sent of the patient. The Cryostat sections (10 Ixm 
9 thick) were processed for histochemical nalysis 
as previously described [4]. A battery of histolog- 
ical and histochemical reactions tests was applied 
(haematoxylin and eosin, modified Gomori tri- 
chrome, ATPase at pH 9.4, 4.6 and 4.3, nicotin- 
amide nucleotide dehydrogenase -NADH, succin- 
ic dehydrogenase -SDH, periodic acid Schiff - 
PAS, phosphorylase, acid phosphatase and oil red 
O). 
Genetic studies now allow a more precise corre- 
lation between phenotype and specific mutations 
to be made, and so genetic analyses were carded 
out in several individuals (V-2; VI-2, VI-3; VI-4) 
using single-strand conformation polymorphism 
analysis to define alleles specific to this PC fa- 
mily. These alleles were then sequenced to inves- 
tigate whether the identified base-pair changes 
corresponded to one of the known amino acid 
substitutions in the $4 helix of domain 4 in the 
adult skeletal muscle sodium channel. 
Polymerase chain reaction was used to amplify 
DNA samples (3 minutes at 94~ • 1; 1 minute at 
94~ 1 minute at 72~ x 30). The reaction buffer 
contained 200 ng of DNA, 0.5 ~M of each pri- 
mer, 70 ~M of each deoxynucleoside triphos- 
phate, 10 mM Tris (pH 8.3), 50 mM KC1, 1.5 mM 
MgC12, 0.01% gelatin, 0.25 Units of Taq poly- 
merase and 0.1 ixl of 32P dCTP (300 Ci/mmol) 
in a volume of 10 I~L. The PCR primers used to 
amplify segments $3-$5 of domain 4 were for- 
ward primer 5' AGCGTCCTCACTAGCTTCTC- 
3' and reverse primer 5'-TGCCCGACTCCTTC- 
TTGAC-3'. Each sample was analyzed using pri- 
mers that amplified about 70% of the sodium 
channel coding sequence. 
Single strand conformation polymorphism (SSCP) 
analysis was then carded out. The PCR products 
were diluted in 50 tzL of a mixture containing 
0.1% SDS and 10 mM EDTA. This mixture was 
further diluted 1:1 with running buffer (95% for- 
mamide, 20 mM EDTA, 0.05% bromphenol blue, 
0.05% xylene cyanol). The diluted samples were 
then denatured for 3 minutes at 94~ and kept on 
ice until 3.5 I,~L of each sample was loaded on 5% 
polyacrylamide g ls (0.4 mm). The reaction prod- 
ucts were electrophoresed using two conditions: a
90 mM Tris-borate (ph 7.5), 2 mM EDTA gel at 
4~ and a 90 mM Tris-borate (pH 7.5), 2 mM 
EDTA, 10% glycerol gel at 25~ Electrophoresis 
was carried out at a constant power of 40W. The 
electrophoresed gels were transferred to What- 
mann 3MM paper and dried on a vacuum slab 
dryer. Autoradiography was performed using Ko- 
dak X-Omat AR film and intensifying screens for 
12-16 hours. 
Aberrant SSCP bands were excised from the dried 
gels and the DNA was eluted in 100 ~1 of dis- 
tilled water. The samples were centrifuged for 1 
minute. New oligonucleotides were synthesized 
and corresponded to the original primers used for 
PCR, which was then performed using these pri- 
mers to amplify a 10 Ixl aliquot of the eluted DNA 
as previously described [23]. The amplified prod- 
ucts were resolved on 4% agarose gels, isolated 
from the gel with Geneclean TM (Bio 101, La 
Jolla, CA) and sequenced using the dideoxy ter- 
mination method [28] with fluorescently tagged 
M13 universal or reverse sequencing primers on 
an Applied Biosystems model 373A DNA se- 
quencer (Applied Biosystems, Foster City, CA). 
Results 
The results of all of the routine blood tests des- 
cribed above were within the normal range. Only 
Case 1 had slightly low levels of K + ions (3 
rnEq/L) due to the therapy she was undergoing; 
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V - 2 : case 1: 52 - yr - old woman,  affected, examined.  
I V - 5 : case 2 : 63 - yr - old man,  affected, examined.  
VI - 2 : case 3 : 31 - yr - old woman,  asymptomat ic ,  examined.  
Vi i  - 1 : daughter  of VI - 2, 5 - yr  - old gid, asymptomat ic .  
VII - 2 : son of VI - 2, 2 - yr - old boy, asymptomat ic .  
VI - 3 : case 4 : 21 - yr - old man,  affected, examined.  
VI - 4 : case 5 : 19 - yr - old man,  most  af fected member ,  examined,  
0 and 9 : aff~ed 
~g. 1. Family tree. The legend indicates the members ofthefamily knowm to be affected by history or because directly 
examined. 
Case 3 showed increased gamma-glutamil-trans- 
ferase and total bilirubin content due to the pres- 
ence of bilestones in the gall-bladder. 
K+ loading gave similar results in all of our pa- 
tients: 90 minutes after K + loading, none of the 
patients has experienced any kind of stiffness and 
all of the blood samples fell within normal range: 
K § never exceeded 4 mEq/L. We interpreted this 
as a negative result. 
The EMG studies carried out under baseline con- 
ditions and after exposure to cold showed evid- 
ence of myotonic and paramyotonic discharges in 
all of the examined muscles (upper and lower 
limbs) of all of our patients. 
Muscle biopsies were performed in all of the af- 
fected members except Case 3, who refused this 
exam. In the other patients, they showed signs of 
neurogenic involvement, especially in relation to 
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type II muscle fibres. 
Genetic analysis using the single-strand confor- 
mation polymorphism technique with primers from 
the hnmarr-skeletat muscle s~.ium channel gene 
revealed an aberrant banding pattern that co-se- 
gregated with the disease in this family (Fig. 2). 
DNA sequencing of the aberrant band revealed a
G A transition at position 4420 in the sodium 
channel gene, which predicts an arginine ~ his- 
tidine change of position 1448 in sodium channel 
protein (Fig. 3). 
Discussion 
The periodic paralyses are a group of clinically 
heterogeneous syndromes in which patients pre- 
sent acute and reversible attacks of muscle weak- 
ness either spontaneously or after exposure to 
various triggering conditions, such as fasting, cold- 
exposure and variations in K § blood levels [22]. 
Muscle function is altered and, although not life- 
threatening because bulbar or respiratory muscles 
are rarely affected, this interferes with normal 
personal and professional activities. The classifi- 
cation of these disorders was initially based on 
blood K § level during attacks, but genetic and 
molecular genetic studies have now led to the 
identification of different groups of disorders: di- 
seases associated with sodium-channel malfunc- 
tion, such as HYPP and PC, and disorders due to 
alterations in chloride-channel function, including 
both dominant (Thomsen) and recessive (Becker) 
MC [9]. HypoPP is another form of periodic par- 
alysis in which linkage to sodium-channel mal- 
function has been excluded [8, 3]; recent studies 
have demonstrated that the dihydropyridine-sen- 
sitive skeletal muscle Ca 2§ channel gene at lq31- 
32 is a plausible candidate for the location of the 
defect in this form of periodic paralysis [2]. 
The described isorders are closely related my- 
opathic forms whose diagnosis is often impossi- 
ble on clinical grounds alone. Although helpful in 
completing the clinical picture, EMG, K + load- 
ing tests and muscle biopsy studies, are often as- 
pecific tools, but genetic analysis now makes it 
possibile to correlate phenotype to genotype when 
an evaluation of an entire family is possible. 
However, this approach does not help in the diag- 
nosis of individual eases. 
The family we describe xemplifies the difficul- 
ties of making a precise diagnosis on purely clin- 
ical grounds. From a clinical viewpoint, the his- 
tory of some our patients contained elements typ- 
ical of both HYPP (weakness was often more 
dominant han myotonia, and exercise reduced 
stiffening in some patients) and PC (with my- 
otonia the predominant symptom and normal K + 
1 2 3 
Fig. 2. SSCP conformers from the SCN4A gene specific 
to PC patients. Lanes 1 and 2 of the SSCP autoradi- 
ograph correspond to controls and Lane 3 corresponds 
to Case 1. The upper arrows indicate normal bands; the 
aberrant band is indicated by the lower arrow. All of the 
examined patients had similar autoradiographs. (See text 
for methodological details). 
levels during attacks); the EMG, K + loading tests 
and muscle biopsy studies were aspecific. 
Single strand conformation polymorphism re- 
vealed a mutation in the sodium channel gene 
predicting a change (and therefore a malfunction) 
in the sodium channel protein responsible for the 
PC phenotype. This mutation occurs in the fourth 
membrane-spanning se ment of domain 4 of the 
sodium channel protein (SCN4A) and alters the 
net charge in the region, but it is distinct from an- 
other that occurs at the same amino acid position 
but leads to the replacement of a basic arginine 
residue by a more neutral histidine (Fig. 3) [21]. 
The subunit involved in the $4 segment is the pu- 
tative "voltage-sensor" of the channel. This seg- 
ment has a high charge density due to the repeat- 
ing motif of a basic amino acid at each position, 
and is thought o move in response to depolari- 
zation thus leading to channel opening. Although 
the cytoplasmic loop between domains 3 and 4 is 
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Paramyotonia Congenita 
A J^ . . . . . . . . .  C 
H 
\ 
Hyperkalemic Periodic Paralysis 
Fig. 3. A sodium channel model h~dicating the sodium channel mutations so fizr identified in patients with PC and HYPP 
phenotypes. The location of  the mutations i shown and named using the one-letter code for the normal amino acid, 
followed by the position (amino acid number) of the mutation and the one-letter code for the amino acid at that posi- 
tion in the mutant. The arrow in tl;e figttre refers to our family's mutation and bldicates that, at position 1448 in the 
sodium channel protein, arginh~e is replaced by hystidine, thus leading to the PC phenotye described. All of  the family 
members examined present this m,r 
M = methionine; T = threonine; R= arginine; H = hystidine; C = cysteine; G = glycine; V = valine; L = leucine. 
thought o serve as the inactivation gate of the 
channel, it is possibile that the conformation f the 
protein resulting from the depolarization of the 
membrane may influence the inactivation of the 
channel. 
This mutation has never before been described in 
Italy. This is important because, although mole- 
cular genetic studies have contributed to the re- 
classification of these disorders, it is now neces- 
sary to consider the prevalence of the different 
phenotypes so far described and attempt a more 
precise therapeutic approach. The number of fam- 
ilies studied at a molecular level is still too small 
to draw definitive conclusions. Studies of more 
families from different ethnic backgrounds might 
help to establish a correlation between genotype 
and phenotype, Once the precise alteration in the 
channel is identified, patch-clamp studies might 
improve our understanding of how this affects 
channel gating in both normal and diseased mus- 
cle, and available drugs such as mexiletine, po- 
tassium-sparing agents, carbonic anhydrase inhib- 
itors, etc. might then be more specifically used 
[14, 30] according to the channel involved and the 
degree of channel gating involvement [27]. 
In agreement with previous reports concerning 
other PC families [1] and the recently described 
acetazolamide-responsive myotonia congenita 
(another disorder linked to the sodium channel 
gene but in which no mutation has yet been de- 
monstrated) [24] we have started treating the pa- 
tients in our family with mexiletine (which raises 
the threshold level of the action potential to more 
positive values and should prevent persistent de- 
polarization). 
Further controls are needed to confirm the suc- 
cess of this therapeutic approach, as well as to 
correlate specific clinical features with distinct 
mutations in an attempt to improve our under- 
standing of channel gating and channel malfunc- 
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tion in periodic paralysis. This understanding can nosis and treatment for patients with non-dys- 
then be translated into improved methods of diag- trophic myotonic disorders. 
Acknowledgment:We would like to thank Alasdair McEwen for having read and revised the text for any error in 
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Sommario 
Le paralisi periodiche costituiscono un gruppo di miopatie a carattere autosomico dominante carat- 
terizzate da episodi transitori crampiformi e da ipostenia. La sintomatologia descritta ~ scatenata so- 
litamente da eccessiva esposizione di alcuni segmenti corporei (solitamente mani, piedi ed orbicolare 
degli occhi) alle basse temperature (come si verifica net cast di paramiotonia congenita, PC) oppu- 
re da variazioni spontanee o indotte del potassio extracellulare (come si verifica net cast di paralisi 
~ er-, HYPP o ipokaliemica, HypoPP). ormai noto che il gene responsabile per le forme di HYPP e di PC ~ localizzato sul cromosoma 17 
e le variazioni fenotipiche correlate indicano chev i  sono varianti alleliche di tali disordini. Finora 
queste forme sono state descritte in numerosi gruppi etnici ma non sono mat state riconosciute in Ita- 
lia. 
Descriviamo una mutazione del segmento $4 del canale muscolare umano del sodio in una famiglia 
italiana con un fenotipo caratteristico per una paramiotonia congenita, a trasmissione autosomica do- 
minante, interessante utti i membri della famiglia da not studiata fin dalla giovane et?t. 
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